Crescendo Bioscience to feature new data on Vectra® DA at 2014 ACR Meeting

(Myriad Genetics, Inc.) Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, will present new data on Vectra DA at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts. The new clinical data support the use of Vectra DA to assess RA disease activity and predict patient risk of joint damage.